Loading stock data…
Medifast (MED)
$9.68+0.23 (+2.43%)
Market ClosedLast close Jul 24
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medifast, Inc. in the Consumer Cyclical sector is trading at $9.68 with a market capitalization of $130M. Wall Street consensus targets $12.00 (1 analysts), implying a +24.0% move over the next 12 months. The stock is currently near its 52-week low of $9.22, remaining 14.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +24.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 28) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $76.04M↑ | $75.10M↓ | $89.41M↓ | $105.56M↓ | $115.73M |
| Gross Profit | $51.76M↓ | $52.14M↓ | $62.16M↓ | $76.64M↓ | $84.25M |
| Operating Income | -$3.29M↑ | -$7.80M↓ | -$4.08M↓ | -$1.07M↑ | -$1.26M |
| Net Income | -$2.12M↑ | -$18.12M↓ | -$2.26M↓ | $2.48M↑ | -$772,000 |
Peer Comparison
AMZNTSLAHD
Fundamentals
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and hea...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$130.09M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-10.13%
Volume
Today's trading volume
207,488
Recent News
Vita Coco Q2 Earnings Beat on Strong Volume, 2026 Guidance Higher
COCO's strong Q2 beat, higher guidance and the Copra acquisition highlight accelerating momentum in coconut water and private label growth.
How Is Post Holdings Rebuilding Its Pet Food Portfolio for Growth?
POST is repositioning its pet food brands with pricing changes and the Nutrish relaunch to improve volumes and category performance.
Can Simpler Pricing Improve Kroger's Customer Retention?
KR is simplifying its pricing strategy to strengthen value perception while funding investments through efficiency gains.
Portfolio Diversification and Premiumization Fuel Molson Coors' Outlook
TAP is leaning on premium beer, acquisitions and its Horizon 2030 strategy to expand beyond brewing and support long-term growth.
Will Medifast's Trilivy Launch Unlock a New Growth Chapter?
Medifast's Trilivy expands beyond weight management with metabolic health support, personalized coaching and a structured three-phase journey.